MLTX
#2431
MoonLake Immunotherapeutics - Class A Ordinary Shares
10.6 9 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.20%
Variazione Mensile
-14.89%
Variazione di 6 mesi
-40.08%
Variazione Annuale
+11.82%
Chiusura Precedente
10.8 2
Open
10.8 2
Minimo
10.6 6
Massimo
10.9 5
Financials
2024
Current report, Q3 FY2024
Moonlake Immunotherapeutics current report, Q3 FY2024
8-K
Quarterly report, Q2 FY2024
Moonlake Immunotherapeutics quarterly report, Q2 FY2024
10-Q
Current report, Q2 FY2024
Moonlake Immunotherapeutics current report, Q2 FY2024
8-K
Current report, 05 Jun 2024
Moonlake Immunotherapeutics current report, 05 June 2024
8-K
Current report, 07 May 2024
Moonlake Immunotherapeutics current report, 07 May 2024
8-K
Quarterly report, Q1 FY2024
Moonlake Immunotherapeutics quarterly report, Q1 FY2024
10-Q
Current report, 10 Mar 2024
Moonlake Immunotherapeutics current report, 10 March 2024
8-K
Current report, 29 Feb 2024
Moonlake Immunotherapeutics current report, 29 February 2024
8-K
Current report, 26 Feb 2024
Moonlake Immunotherapeutics current report, 26 February 2024
8-K
2023
Annual report, FY2023
Moonlake Immunotherapeutics annual report, FY2023
10-K